Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
inactivated hepatitis A vaccine (adsorbed)
- Development stage
- Unknown
- Lead developer
- Zydus Lifesciences
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
This inactivated hepatitis A vaccine (adsorbed) is a prophylactic candidate developed by Zydus Lifesciences for the prevention of Hepatitis A virus infection. The vaccine utilizes killed hepatitis A virus particles that have been adsorbed onto an adjuvant, typically aluminum hydroxide, to enhance the host's immune response. By presenting inactivated viral antigens, the vaccine stimulates the production of neutralizing antibodies without the risk of causing the disease. As of the current pipeline information, this candidate is in Phase 1 clinical development, representing an expansion of Zydus's established vaccine portfolio which includes products for influenza, rabies, and COVID-19.
- Other names
- Zydus Hepatitis A vaccineinactivated hepatitis A vaccine (adsorbed)-Zydus Lifesciences-vaccine (inactivated)-Hepatitis A
Beyond the preview
Go deeper on inactivated hepatitis A vaccine (adsorbed).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on inactivated hepatitis A vaccine (adsorbed).